OTC · Biotechnology

GB Sciences, Inc. (GBLX) Stock

$0.00 OTC: GBLX Healthcare

Operating across North America and Europe, GB Sciences, Inc. is dedicated to the research and development of plant-based pharmaceuticals.

Valuation

MetricValue
Price$0.00
Market Cap$122121
P/E Ratio-0.07
P/B Ratio-0.02
P/S Ratio1.26
EPS (TTM)$0.00
52-Week High$0.50
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE20.00%
ROA-438.99%
ROCE
Gross Margin100.00%
Operating Margin-68.48%
Net Margin0.00%
Debt/Equity-0.40
Current Ratio0.02

Annual Financials (USD)

Metric20192020202120222023
Revenue$3.0M$0$0$0$0
Operating Profit$-12.0M$-2.0M$-2.0M$-2.0M$-1.0M
Net Profit$-12.0M$-4.0M$-1.0M$-4.0M$-1.0M
EPS$-0.04$-0.01$0.00$-0.01$0.00
Op Margin-384.8%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$14.0M$11.0M$3.0M$0$0
Total Liabilities$14.0M$12.0M$4.0M$5.0M$5.0M
Cash$0$1.0M$0$0$0
Borrowings$9.0M$4.0M$1.0M$1.0M$2.0M

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-4.0M$-2.0M$-2.0M$-2.0M$-1.0M
Investing Cash Flow$-1.0M$4.0M$1.0M$0$0
Financing Cash Flow$1.0M$0$0$0$0
Net Cash Flow$0$1.0M$-1.0M$0$0
Free Cash Flow$-5.0M$-2.0M$-2.0M$-2.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.32
FCF Yield-818.86%
Quick Ratio0.02
Interest Coverage-6.49
Return 1Y
Return 3Y
Return 5Y

Ownership

Insiders Held0.00%
Institutions Held0.08%
Institutions Float Held0.08%
Institutional HolderSharesReport Date
Kingswood Wealth Advisors, LLC200,0002026-06-30
Stonekeep Investments, LLC 104,9302026-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About GB Sciences, Inc.

Operating across North America and Europe, GB Sciences, Inc. is dedicated to the research and development of plant-based pharmaceuticals. The company specializes in crafting cannabinoid-inspired medications and complex therapeutic formulations intended for the prescription drug market. Its extensive intellectual property portfolio addresses a variety of medical conditions, with programs currently in pre-clinical animal stages. These include initiatives for Parkinson's disease, neuropathic and chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular ailments. Formed in 2001 and headquartered in Las Vegas, Nevada, the company was formerly known as Growblox Sciences, Inc. before rebranding in October 2016.

GB Sciences, Inc. (GBLX) stock trades at $0.00 with a market capitalization of $122121. The stock is valued at a price-to-earnings (P/E) ratio of -0.07, price-to-book of -0.02, price-to-sales of 1.26. Over the past 52 weeks the stock has ranged between $0.00 and $0.50, and currently trades 100.0% below its 52-week high.

On profitability, GB Sciences, Inc. generates a return on equity (ROE) of 20.00%, above the typical market average, an operating margin of -68.48%, a net profit margin of 0.00%.

Official website: www.gbsciences.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides